Rational design of nano- and micro-size medicinal forms of biologically active substances

Applied Biochemistry and Microbiology

Volumn 47, Issue 8, 2011, Pages 711-717

  Kaplun, A P ^a   Bezrukov, D A ^a   Shvets, V I ^a  

^a MIREA RUSSIAN TECHNOLOGICAL UNIVERSITY   (Russian Federation)

Author keywords

active targeting; adjuvant; controllable release; liposomes; microparticles; nanoparticles; passive targeting; solubilization

Indexed keywords

EID: 81155135271     PISSN: 00036838     EISSN: None     Source Type: Journal    
DOI: 10.1134/S0003683811080072     Document Type: Review

References (70)

1. Vinogradov, S. V., Bronich, T. K., and Kabanov, A. V., Adv. Drug Deliv. Rev., 2002, vol. 54, pp. 135-147.
2. Choi, H. S., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Ipe, B. I., Bawendi, M. G., and Frangioni, J. V., Nature Biotech., 2007, vol. 25, pp. 1165-1170.
3. Moghimi, S. M., Hunter, A. C., and Murray, J. C., Pharmacol. Rev., 2001, vol. 53, pp. 283-318.
4. Ilium, L., Davis, S. S., Wilson, C. G., Thomas, N. W., Frier, M., and Hardy, J. G., Int. J. Pharm., 1982, vol. 12, pp. 135-146.
5. Moghimi, S. M., Hedeman, H., Muir, I. S., Illum, L., and Davis, S. S., Biochim. Biophys. Acta, 1993, vol. 1157, pp. 233-240.
6. Porter, C. J, Moghimi, S. M., Illum, L., and Davis, S. S., FEBS Lett., 1992, vol. 305, pp. 62-66.
7. Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., and Jain, R. K., Proc. Natl. Acad. Sci. USA, 1998, vol. 95, pp. 4607-4612.
8. Pluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., Tomaso, E. Di., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., and Jain, R. K., Proc. Natl. Acad. Sci. USA, 2001, vol. 98, pp. 4628-4633.
9. Barua, S., and Rege, K., Small, 2009, vol. 5, pp. 370-376.
10. Duncan, R., Pratten, M. K., Cable, H. C., Ringsdorf, H., and Lloyd, J. B., Biochem. J., 1980, vol. 196, pp. 49-55.
11. Champion, J. A., Katare, Y. K., and Mitragotri, S., J. Contr. Release, 2007, vol. 121, pp. 3-9.
12. Doshi, N., Prabhakarpandian, B., Rea-Ramsey, A., Pant, K., Sundaram, S., and Mitragotri, S., J. Contr. Release, 2010, vol. 146, pp. 196-200.
13. Decuzzi, P., Godin, B., Tanaka, T., Lee, S. Y., Chiappini, C., Liu, X., and Ferrari, M., J. Contr. Release, 2010, vol. 141, pp. 320-327.
14. Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., and DeSimone, J. M., Proc. Natl. Acad. Sci. USA, 2008, vol. 105, pp. 11613-11618.
15. Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., and Discher, D. E., Nature Nanotech., 2007, vol. 2, pp. 249-255.
16. US Food and Drug Administration. Drugs. US FDA website [online], 2010 http://www. accessdata. fda. gov/scripts/cder/drugsatfda/index. cfm.
17. Huang, S. K., Mayhew, E., Gilani, S., Lasic, D. D., Martin, F. J., and Papahadjopoulos, D., Cancer Res., 1992, vol. 52, pp. 6774-6781.
18. Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., and Redemann, C., Proc. Natl. Acad. Sci. USA, 1991, vol. 88, pp. 11460-11464.
19. Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., and OShaughnessy, J., J. Clin. Oncol., 2005, vol. 23, pp. 7794-7803.
20. Lee, C. C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Frechet, J. M. J., Dy, E. E., and Szoka, F. C., Proc. Natl. Acad. Sci. USA, 2006, vol. 103, pp. 16649-16654.
21. Gabizon, A., and Papahadjopoulos, D., Proc. Natl. Acad. Sci. USA Med. Sci., 1988, vol. 85, pp. 6949-6953.
22. Tabata, Y. and Ikada, Y., Biomaterials, 1988, vol. 9, no. 4, pp. 356-362.
23. Ayhan, H., Tuncel, A., Bor, N., and Piskin, E., J. Biomater. Sci. Polym. Ed., 1995, vol. 7, no. 4, pp. 329-342.
24. Buzea, C., Blandino, I. I. P., and Robbie, K., Biointerphases, 2007, vol. 2, p. MR17-MR172.
25. Minina, A. V., Malikova, N. M., Sorokoumova, G. M., Selishcheva, A. A., and Shvets, V. I., Byull. Eksperim. Biol. Med., 2004, vol. 137, no. 1, pp. 24-26.
26. http://thesaurus. rusnano. com/wiki/article1399?phrase-id=33623.
27. Krasilnikov, I. V., Gambaryan, A. S., Mashin, V. V., and Lobastova, A. K., Vopr. Virusol., 2010, no. 2, pp. 24-29.
28. Zhigaltsev, I. V., Kaplun, A. P., Kucheryanu, V. G., Kryzhanovsky, G. N., Shvets, V. I., and Yurasov, V. V., J. Liposome Res., 2001, vol. 11, no. 1, pp. 55-71.
29. Yurasov, V. V., Zhigaltsev, I. V., Kucheryanu, V. G., Kudrin, V. S., Kaplun, A. P., and Shvets, V. I., J. Liposome Res., 1998, vol. 8, no. 1, p. 73.
30. Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., and Kreuter, J., Pharm. Res., 1999, vol. 16, no. 10, pp. 1564-1569.
31. Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., and Alyautdin, R., J. Drug Target, 2002, vol. 10, no. 4, pp. 317-325.
32. Liu, G., Men, P., Perry, G., and Smith, M. A., J. Nanoneurosci., 2009, vol. 1, no. 1, pp. 42-55.
33. Pereverzeva, E., Treschalin, I., Bodyagin, D., Maksimenko, O., Kreuter, J., an Gelperina, S., Toxicology Lett., 2008, vol. 178, pp. 9-19.
34. Gelperina, S. E., Smirnova, Z. S., Khalanskii, A. S., Skidan, I. N., S. E. Severin, and Kroiter, I., Ros. Bioterapevt. Zh., 2004, vol. 3, no. 3, pp. 56-64.
35. Kucheryanu, V. G., Yurasov, V. V., Kryzhanovskii, G. N., Nikushkin, E. V., Zhigaltsev, I. V., Kaplun, A. P., and Shvets, V. I., Byul. Eksperim. Biol. Med., 1997, vol. 123, no. 1, pp. 29-33.
36. Kaplun, A. P., Bagrov, S. N., Novikov, S. V., Lozinskaya, O. L., and Shvets, V. I., RF Patent No. 2179026, 2002.
37. Mantripragada, S., Prog. Lipid Res., 2002, vol. 41, pp. 392-406.
38. Angst, M. S. and Drover, D. R., Clin. Pharmacokinet., 2006, vol. 45, no. 12, pp. 1153-1229.
39. Marcato, P. D. and Duran, N., J. Nanosci. Nanotechnol., 2008, vol. 8, pp. 1-14.
40. Allen, T. M. and Cullis, P. R., Science, 2003, vol. 303, pp. 1818-1822.
41. Kripp, M. and Hofheinz, R. D., Int. J. Nanomedicine, 2008, vol. 3, no. 4, pp. 397-401.
42. Zimm, S., Collins, J. M., and Miser, J., Clin. Pharmacol. Ther., 1984, vol. 35, pp. 826-856.
43. Nagle, P. C. and Gerancher, J. C., Tech. Reg. Anesth. Pain Manage, 2007, vol. 11, pp. 9-18.
44. Pasero, C. and McCaffery, M., J. Perianesth. Nurs., 2005, vol. 20, pp. 345-350.
45. Rishton, G. M., Drug Discovery Today, 2003, vol. 8, no. 2, pp. 86-96.
46. Strickley, R. G., Pharm. Res., 2004, vol. 21, pp. 201-230.
47. Le Vang, Sh., Kaplun, A. P., Shpilevskii, A. A., Andiya-Pravdivyi, Yu. E., S. G. Alekseeva, V. B. Grigor'ev, V. I. Shvets, Bioorgan. Khim., 1998, vol. 24, no. 10, pp. 787-793.
48. Bastrich, A. N., Krasilnikova, V. V., Lyu, T. N., Popenko, V. I., Kaplun, A. P., Balakshin, V. V., Presnova, G. A., and Chistyakov, A. N., Biotekhnologiya, 2008, no. 6, pp. 51-59.
49. Gabizon, A., Shmeeda, H., Horowitz, A. T., and Zalipsky, S., Adv. Drug Deliv. Rev., 2004, vol. 56, pp. 1177-1192.
50. Daniels, T. R., Delgado, G., Helguera, and M. L. Penichet, Clin. Immunol., 2006, vol. 121, pp. 159-176.
51. Choi, C. H., Alabi, C. A., Webster, P., and Davis, M. E., Proc. Natl. Acad. Sci. USA, 2010, vol. 107, pp. 1235-1240.
52. Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., and Cheresh, D. A., Proc. Natl. Acad. Sci. USA, 2008, vol. 105, no. 27, pp. 9343-9348.
53. Chang, S. S., O'Keefe, D. S., Bacich, D. J., Reuter, V. E., Heston, W. D. W., and Gaudin, P. B., Clin. Cancer Res., 1999, vol. 5, pp. 2674-2681.
54. Milowsky, M. I., Nanus, D. M., Kostakoglu, L., Sheehan, C. E., Vallabhajosula, S., Goldsmith, S. J., Ross, J. S., and Bander, N. H., J. Clin. Oncol., 2007, vol. 25, pp. 540-547.
55. Petros, R. A. and DeSimone, J. M., Nature Rev./Drug Discovery, 2010, vol. 9, pp. 615-627.
56. Breunig, M., Bauer, S., and Goepferich, A., Eur. J. Pharmac. Biopharmac., 2008, vol. 68, pp. 112-128.
57. Drummond, D. C., M. Zignani, J. C. Leroux, Prog. Lip. Res., 2000, vol. 39, pp. 409-460.
58. Vasir, J. K. and Labhasetwar, V., Adv. Drug Deliv. Rev., 2007, vol. 59, pp. 718-728.
59. Ulbrich, K. and Subr, V., Adv. Drug Deliv. Rev., 2004, vol. 56, pp. 1023-1050.
60. Pouton, C. W., Wagstaff, K. M., Roth, D. M., Moseley, G. W., and Jans, D. A., Adv. Drug Delivery Rev., 2007, vol. 59, pp. 698-717.
61. Gu, Y. J., Cheng, J., Lin, C. C., Lam, Y. W., Cheng, S. H., and Wong, W. T., Toxicol. Appl. Pharmacol., 2009, vol. 237, pp. 196-204.
62. Misra, R. and Sahoo, S. K., Eur. J. Pharm. Sci., 2010, vol. 39, pp. 152-163.
63. Mukhopadhyay, A. and H. Weiner, Adv. Drug Deliv. Rev., 2007, vol. 59, pp. 729-738.
64. Yuma Yamada, Hideyoshi Harashima, Adv. Drug Deliv. Rev., 2008, vol. 60, pp. 1439-1462.
65. Yousif, L. F., K. M. Stewart, and Kelley, S. O., Chembiochem, 2009, vol. 10, pp. 1939-1950.
66. Terlecky, S. R., and Koepke, J. I., Adv. Drug Deliv. Rev, 2007, vol. 59, pp. 739-747.
67. Kong, G., Anyarambhatla, G., Petros, W. P., Braun, R. D., Colvin, O. M., Needham, D., and Dewhirst, M. W., Cancer Res., 2000, vol. 60, pp. 6950-6957.
68. Chia-Lung Lin, Wen-Yen Chiu, Chia-Fen Lee, J. Colloid Interface Sci., 2005, vol. 290, pp. 397-405.
69. Bezrukov, D. A., Koroleva, A. I., Kaplun, A. P., Lantsova, A. V., Orlova, O. L., and Oborotova, N. A., Ros. Terap. Zh., 2006, vol. 5, no. 4, pp. 79-83.
70. Farokhzad, I. N. and Langer, R., ACS Nano, 2009, vol. 3, pp. 16-20.